• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VIR

VIR

Vir Biotechnology, Inc.

NASDAQHealthcareBiotechnologyUS

USD8.77

+0.03 (+0.34%)

Rating:C

Company Profile

CEO

Marianne De Backer

IPO Date

2019-10-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$8.87

Prev. Close

$8.74

Day Low

$8.68

Day High

$9.03

52W Low

$4.16

52W High

$11.66

Market Cap

$1.48B

Volume

2.34M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

76.4%

Avg Negative

3.0%

Avg Neutral

20.8%

News Feed

Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment

Market Watch·7/28/2021·↑ positive

GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab

GlobeNewsWire·7/28/2021·↑ positive

Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2021 Financial Results on August 5, 2021

GlobeNewsWire·7/22/2021·↓ negative

Vir Biotech (VIR) Begins Dosing in Phase II Hepatitis B Study

Zacks Investment Research·7/16/2021·↑ positive

Vir Biotechnology Starts Dosing In Mid-Stage Hepatitis B Trial With Combination Therapy

Benzinga·7/15/2021·↑ positive

GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should Know

The Motley Fool·7/1/2021·↑ positive

Vir Biotech's HBV Candidates Show Positive Safety Profiles

Benzinga·6/25/2021·↑ positive

Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021

GlobeNewsWire·6/25/2021·↑ positive

Glaxo (GSK)/Vir Affirm COVID-19 Drug Cuts Hospitalization/Death

Zacks Investment Research·6/22/2021·↑ positive

GSK - Vir Biotech's Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients

Benzinga·6/21/2021·↑ positive